News headlines about Polarityte (NASDAQ:COOL) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Polarityte earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 45.1134757986273 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
A number of equities research analysts have recently weighed in on COOL shares. Cantor Fitzgerald set a $70.00 target price on Polarityte and gave the stock a “buy” rating in a report on Tuesday, February 20th. ValuEngine raised Polarityte from a “sell” rating to a “hold” rating in a report on Friday, February 2nd.
Polarityte (COOL) traded down $1.00 on Wednesday, hitting $17.50. The stock had a trading volume of 189,099 shares, compared to its average volume of 131,318. Polarityte has a 12 month low of $7.40 and a 12 month high of $32.63.
PolarityTE, Inc, formerly Majesco Entertainment Company, is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. The Company seeks to develop and obtain regulatory approval for technology that will utilize a patient’s own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves.
Receive News & Ratings for Polarityte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarityte and related companies with MarketBeat.com's FREE daily email newsletter.